guaifenesin has been researched along with Diabetes Mellitus, Type 2 in 3 studies
Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Aggarwal, V | 1 |
Sunder, S | 1 |
Verma, SR | 1 |
Shi, Y | 1 |
Liu, L | 1 |
Yin, M | 1 |
Zhao, Z | 1 |
Liang, Y | 1 |
Sun, K | 1 |
Li, Y | 1 |
Sintsova, O | 1 |
Gladkikh, I | 1 |
Kalinovskii, A | 1 |
Zelepuga, E | 1 |
Monastyrnaya, M | 1 |
Kim, N | 1 |
Shevchenko, L | 1 |
Peigneur, S | 1 |
Tytgat, J | 1 |
Kozlovskaya, E | 1 |
Leychenko, E | 1 |
1 review available for guaifenesin and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Disease-associated dysbiosis and potential therapeutic role of Akkermansia muciniphila, a mucus degrading bacteria of gut microbiome.
Topics: COVID-19; Diabetes Mellitus, Type 2; Dysbiosis; Gastrointestinal Microbiome; Humans; Mucins; Mucus; | 2022 |
2 other studies available for guaifenesin and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Mucus- and pH-mediated controlled release of core-shell chitosan nanoparticles in the gastrointestinal tract for diabetes treatment.
Topics: Administration, Oral; Animals; Chitosan; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Dru | 2023 |
Magnificamide, a β-Defensin-Like Peptide from the Mucus of the Sea Anemone
Topics: alpha-Amylases; Amino Acid Sequence; Animals; beta-Defensins; Blood Glucose; Cnidarian Venoms; Diabe | 2019 |